Evidence map›Paper›PMID 26447924›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2016

A benchmark for evaluation of algorithms for identification of cellular correlates of clinical outcomes.

Nima Aghaeepour, Pratip Chattopadhyay, Maria Chikina, Tom Dhaene, Sofie Van Gassen, Miron Kursa, Bart N Lambrecht, Mehrnoush Malek, G J McLachlan, Yu Qian and 13 more

Abstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. PeacoQC: Peak-based selection of high quality cytometry data.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Article
  7. Article
  8. CytoPy: An autonomous cytometry analysis framework.PLoS computational biology · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Improving the Rigor and Reproducibility of Flow Cytometry-Based Clinical Research and Trials Through Automated Data Analysis.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. An integrated framework using high-dimensional mass cytometry and fluorescent flow cytometry identifies discrete B cell subsets in patients with red meat allergy.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Article
  20. How Clinical Flow Cytometry Rebooted Sepsis Immunology.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Nima AghaeepourTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Pratip ChattopadhyayImmunoTechnology Section, Vaccine Research Center, National Institutes of Health, Washington, DC.
Maria ChikinaDepartment Computational and Systems Biology, University of Pittsburgh, Pittsburg, Pennsylvania.
Tom DhaeneDepartment of Information Technology, Ghent University-iMinds, Ghent, Belgium.
Sofie Van GassenDepartment of Information Technology, Ghent University-iMinds, Ghent, Belgium.
Miron KursaInterdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw, Warsaw, Poland.
Bart N LambrechtInflammation Research Center, VIB, Ghent, Belgium.
Mehrnoush MalekTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
G J McLachlanDepartment of Statistics, University of Queensland, St. Lucia, Brisbane, Australia 4072.
Yu QianJ. Craig Venter Institute, La Jolla, California.
Peng QiuDepartment of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia.
Yvan SaeysInflammation Research Center, VIB, Ghent, Belgium.
Rick StantonJ. Craig Venter Institute, La Jolla, California.
Dong TongThe John Van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom.
Celine VensInflammation Research Center, VIB, Ghent, Belgium.
Sławomir WalkowiakInterdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw, Warsaw, Poland.
Kui WangDepartment of Mathematics, University of Queensland, St. Lucia, Brisbane, Australia.
Greg FinakVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC.
Raphael GottardoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC.
Tim MosmannDavid H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, Rochester, New York.
Garry P NolanBaxter Laboratory in Stem Cell Biology, Stanford University, Stanford, California.
Richard H ScheuermannJ. Craig Venter Institute, La Jolla, California.
Ryan R BrinkmanTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NOLAN, GARRY P · 2012 to 2021
$49.1M
MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMAU54CA149145 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2010 to 2014
$12.1M
Human Immunology Center at the University of RochesterR24AI054953 · NIAID · UNIVERSITY OF ROCHESTER · PI MOSMANN, TIM R. · 2003 to 2012
$8.8M
The Statistical and Computational Analysis of Flow Cytometry DataR01EB008400 · NIBIB · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOTTARDO, RAPHAEL · 2008 to 2015
$2.9M
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian CancersR01CA184968 · NCI · STANFORD UNIVERSITY · PI FANTL, WENDY JANE, SIKIC, BRANIMIR I · 2014 to 2017
$2.0M
Highly multiplexed ion-beam tissue molecular imaging with sub-micron resolutionR33CA183654 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2014 to 2016
$1.2M
Integrating mass cytometric and transcriptomic profiles of solid tumorsR33CA183692 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2014 to 2016
$1.2M
Identifying the cellular hierarchy and drug response of AML using cytometric dataR01CA163481 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI QIU, PENG · 2012 to 2015
$1.1M
NCI NIH HHS 1 R33 CA183654NCI NIH HHS 1R33CA18365401NCI NIH HHS 1R33CA183692NCI NIH HHS 1R33CA183692-01NCI NIH HHS CA184968NCI NIH HHS CVNCI R01CA163481NCI NIH HHS R01 CA163481NCI NIH HHS R01 CA184968NCI NIH HHS R01CA184968NCI NIH HHS R33 CA183654NCI NIH HHS R33 CA183692NCI NIH HHS U54 CA149145NCI NIH HHS U54CA149145NHLBI NIH HHS N01-HV-00242NIAID NIH HHS 1U19AI100627NIAID NIH HHS 5R01AI07372405NIAID NIH HHS R24 AI054953NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI100627NIBIB NIH HHS NIBIB EB008400NIBIB NIH HHS R01 EB008400PHS HHS A1073724PHS HHS NIH152175.5041015.0412PHS HHS NIH/NIAID R24AI054953
6 · The paper itself

Abstract

The Flow Cytometry: Critical Assessment of Population Identification Methods (FlowCAP) challenges were established to compare the performance of computational methods for identifying cell populations in multidimensional flow cytometry data. Here we report the results of FlowCAP-IV where algorithms from seven different research groups predicted the time to progression to AIDS among a cohort of 384 HIV+ subjects, using antigen-stimulated peripheral blood mononuclear cell (PBMC) samples analyzed with a 14-color staining panel. Two approaches (FlowReMi.1 and flowDensity-flowType-RchyOptimyx) provided statistically significant predictive value in the blinded test set. Manual validation of submitted results indicated that unbiased analysis of single cell phenotypes could reveal unexpected cell types that correlated with outcomes of interest in high dimensional flow cytometry datasets.

Indexed as

BenchmarkingDisease ProgressionAcquired Immunodeficiency SyndromeAlgorithmsComputational BiologyData Interpretation, StatisticalFlow CytometryHIV SeropositivityHumansStaining and LabelingT-Lymphocytesbioinformaticsclassificationclinical outcomeclusteringdata analysisflow cytometryHIVsupervised analysis

Identifiers

PMID26447924
PMCPMC4874734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.